Switch to:
More From Other Websites
Will BioMarin (BMRN) Disappoint This Earnings Season? Oct 21 2014
Some Potential Targets for Shire to Buy With $1.6B in Free Money Oct 21 2014
BIOMARIN PHARMACEUTICAL INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Oct 14 2014
BioMarin to Host Third Quarter 2014 Financial Results Conference Call and Webcast on Thursday,... Oct 08 2014
Catalyst Pharma Closer to Unconscionable Price Hike for Rare-Disease Drug Sep 30 2014
Catalyst Pharma's lead drug succeeds in late-stage study Sep 29 2014
BioMarin (BMRN) Faces Threat of Genericization for Kuvan Sep 25 2014
5 Orphan Drug Biotech Stocks to Buy With Big Upside Potential Sep 25 2014
FDA Receives Paragraph IV Notice Letter for KUVAN(R) (sapropterin dihydrochloride) Tablets Sep 24 2014
BioMarin to Attend Upcoming Investor Conferences Sep 23 2014
Roche's $8 billion InterMune buy not a signal for more big deals Sep 16 2014
BioMarin Named by CenterWatch as One of the Fastest Developers of Medicines Sep 15 2014
BioMarin to Attend Upcoming Investor Conferences in London Sep 10 2014
Merck KGaA's Kuvan Effective in Under-4 Year Olds Sep 05 2014
Biotech Stock Roundup: United Therapeutics Up on Court Ruling, Amgen Files PCSK9 Inhibitor Sep 03 2014
Early data suggest Sanofi, Regeneron drug may halve heart risk Aug 31 2014
Early data suggest Sanofi, Regeneron drug may halve heart risk Aug 31 2014
BioMarin Cuts '14 Revenue View after Voucher Sale Evaluation Aug 27 2014
Can BioMarin Pharmaceutical (BMRN) Run Higher on Strong Earnings Estimate Revisions? Aug 27 2014
BIOMARIN PHARMACEUTICAL INC Files SEC form 8-K/A, Results of Operations and Financial Condition Aug 26 2014


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK